QNCX Earnings

Quarterly EPS
$-128.00
Q2 2024
$-26.00
Q3 2024
$-56.00
Q4 2024
$-68.40
Q1 2025
$-68.00
Q2 2025
$-50.00
Q3 2025
$-152.00
Q4 2025
$72.00
Q1 2026
Latest RevenueN/A
Latest Net Income35.9M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026$72.0035.9M+205.3%
Q4 2025-$152.00-39458000-171.4%
Q3 2025-$50.00-13442000-92.3%
Q2 2025-$68.00-16049000+46.9%
Q1 2025-$68.40-15030000-31.5%
Q4 2024-$56.00-12458000-33.3%
Q3 2024-$26.00-5492000+13.3%
Q2 2024-$128.00-27729000-357.1%
Q1 2024-$52.00-11149000
Q4 2023-$42.00-8894000
Q3 2023-$30.00-5351000
Q2 2023-$28.00-4886000
Quince Therapeutics (QNCX) — Earnings